Alzheimer's disease (AD) is a neurodegenerative disease characterized by severe cognitive deterioration. While causes of AD pathology are debated, a large body of evidence suggests that increased cleavage of Amyloid Precursor Protein (APP) producing the neurotoxic Amyloid-β (Aβ) peptide plays a fundamental role in AD pathogenesis. One of the detrimental behavioral symptoms commonly associated with AD is the fragmentation of sleep-activity cycles with increased nighttime activity and daytime naps in humans. Sleep-activity cycles, as well as physiological and cellular rhythms, which may be important for neuronal homeostasis, are generated by a molecular system known as the circadian clock. Links between AD and the circadian system are increasingly evident but not well understood. Here we examined whether genetic manipulations of APP-like (APPL) protein cleavage in Drosophila melanogaster affect rest-activity rhythms and core circadian clock function in this model organism. We show that the increased β-cleavage of endogenous APPL by the β-secretase (dBACE) severely disrupts circadian behavior and leads to reduced expression of clock protein PER in central clock neurons of aging flies. Our data suggest that behavioral rhythm disruption is not a product of APPL-derived Aβ production but rather may be caused by a mechanism common to both α and β-cleavage pathways. Specifically, we show that increased production of the endogenous Drosophila Amyloid Intracellular Domain (dAICD) caused disruption of circadian rest-activity rhythms, while flies overexpressing endogenous APPL maintained stronger circadian rhythms during aging. In summary, our study offers a novel entry point toward understanding the mechanism of circadian rhythm disruption in Alzheimer's disease.
Introduction
Alzheimer's disease (AD) is characterized by progressive neurodegeneration resulting in the loss of cognitive ability. The exact pathology of AD is not well understood and is widely debated. The amyloid cascade hypothesis suggests that abnormal production of neurotoxic Amyloid-beta (Aβ) in combination with tangles of phosphorylated Tau-microtubule associated protein lead to neuronal dysfunction, cell loss and thus cognitive decline (Hardy and Selkoe, 2002; Mandelkow and Mandelkow, 1998; Selkoe, 2000) . The crucial enzyme in the production of Aβ is the rate-limiting Beta-site Amyloid Precursor Protein Cleaving Enzyme (BACE), which shows elevated expression in AD patients (Fukumoto et al., 2002; Vassar et al., 2009) . Recently, knock-in of human BACE was shown to recapitulate many behavioral and physiological phenotypes of AD in a murine model (Plucinska et al., 2014) . In addition to BACE, Amyloid Precursor Protein (APP) is cleaved by an α-secretase. Both cleavage pathways yield a secreted N-terminal fragment known as sAPP, sAPPβ for β-cleavage and sAPPα for α-cleavage. Subsequent ϒ-cleavage following β or α-cleavage results in either the Aβ or P3 fragment, respectively (De Strooper and Annaert, 2000; Selkoe, 2000; Turner et al., 2003) . In addition to those two fragments, ϒ-cleavage also produces the APP intracellular domain (AICD), which has been shown to affect transcriptional regulation (Belyaev et al., 2010; Kimberly et al., 2001; Pardossi-Piquard and Checler, 2012; Turner et al., 2003) . Both detrimental and positive effects of the AICD have been reported in cultured cells (Lu et al., 2000; Zhou et al., 2012) ; however, the physiological function of the AICD remains poorly understood.
One of the detrimental behavioral symptoms commonly associated with AD is the fragmentation of sleep-activity cycles with increased nighttime activity and daytime naps (Harper et al., 2005; Volicer et al., 2001; Wu and Swaab, 2007) . Impaired rest-activity rhythms have also Neurobiology of Disease 77 (2015) 117-126 
